# PDE5i Use in Renal Transplant Recipients

> **NCT04122105** · NA · WITHDRAWN · sponsor: **University of British Columbia**

## Conditions studied

- Renal Transplant Failure

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT04122105
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** iss
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122105, "PDE5i Use in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04122105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*